Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function.
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Tani J, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, Yonezawa T, Tanaka S, Deguchi A, Shimose S, Shirono T, Sakai M, Suzuki H, Moriyama E, Koga H, Torimura T, Kawaguchi T, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan. Iwamoto H, et al. Among authors: kooka y. Cancers (Basel). 2022 Oct 5;14(19):4873. doi: 10.3390/cancers14194873. Cancers (Basel). 2022. PMID: 36230795 Free PMC article.
Coincidental items in the definition of metabolic dysfunction-associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver.
Kakisaka K, Kuroda H, Abe T, Nakaya I, Watanabe T, Yusa K, Sato H, Suzuki A, Kooka Y, Endo K, Yoshida Y, Oikawa T, Miyasaka A, Matsumoto T. Kakisaka K, et al. Among authors: kooka y. Hepatol Res. 2023 Sep;53(9):857-865. doi: 10.1111/hepr.13928. Epub 2023 Jun 15. Hepatol Res. 2023. PMID: 37269213
Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic Scores.
Kakisaka K, Nakayama N, Kumagai K, Hisanaga T, Kondo T, Setsu T, Sato S, Kooka Y, Endo K, Yoshida Y, Oikawa T, Kuroda H, Miyasaka A, Abe R, Nakada TA, Ikura Y, Harada K, Genda T, Terai S, Kato N, Takami T, Ido A, Mochida S, Matsumoto T, Tanaka A. Kakisaka K, et al. Among authors: kooka y. Gastro Hep Adv. 2023 Feb 9;2(4):497-504. doi: 10.1016/j.gastha.2023.02.002. eCollection 2023. Gastro Hep Adv. 2023. PMID: 39132042 Free PMC article.
Lactulose: A treatment for hyperammonemia in a lysinuric protein-intolerant patient with dynamic blood amino acid concentrations.
Kakisaka K, Sato T, Wada Y, Ito A, Eto H, Abe H, Kanazawa J, Yusa K, Kooka Y, Endo K, Yoshida Y, Oikawa T, Kuroda H, Miyasaka A, Akasaka M, Matsumoto T. Kakisaka K, et al. Among authors: kooka y. Mol Genet Metab Rep. 2022 Jul 15;32:100898. doi: 10.1016/j.ymgmr.2022.100898. eCollection 2022 Sep. Mol Genet Metab Rep. 2022. PMID: 35865266 Free PMC article. No abstract available.
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Nomura T, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, Yonezawa T, Ishihara A, Deguchi A, Arai H, Shimose S, Shirono T, Nakano M, Okamura S, Noda Y, Kamachi N, Sakai M, Suzuki H, Aino H, Matsukuma N, Matsugaki S, Ogata K, Yano Y, Ueno T, Kajiwara M, Itano S, Fukuizumi K, Kawano H, Noguchi K, Tanaka M, Yamaguchi T, Kuromatsu R, Kawaguchi A, Koga H, Torimura T, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan. Iwamoto H, et al. Among authors: kooka y. Cancers (Basel). 2021 Feb 5;13(4):646. doi: 10.3390/cancers13040646. Cancers (Basel). 2021. PMID: 33562793 Free PMC article.
15 results